血管内超声评估在药物涂层球囊治疗股腘动脉病变中预测再狭窄的附加价值
本研究回顾性纳入2021至2023年接受血管内超声(IVUS)指导下药物涂层球囊(DCB)治疗的111例患者共147处股腘动脉病变,评估术后IVUS测得足够管腔面积(≥12.7 mm²)能否独立于经典风险因素预测1年再狭窄。
要点
- IVUS测得术后管腔面积≥12.7 mm²与DCB治疗后1年再狭窄风险降低独立相关。
- 经典风险评分(含CTO、膝下流出道不良等)仍是再狭窄的独立预测因子。
- 将IVUS管腔面积纳入围手术期评估可能有助于风险分层与术后监测规划。
核心结论
- IVUS评估可能与DCB治疗后再狭窄发生相关,且独立于经典风险因素。
研究设计与样本
- 回顾性研究,纳入2021至2023年接受IVUS指导下DCB治疗的111例患者共147处股腘动脉病变。
主要发现
- 1年再狭窄见于38处病变(26%)。
关键数值与推荐
- 足够管腔面积定义为IVUS测得≥12.7 mm²。
- 经典风险评分包括无膝下流出道、既往EVT史、远端参考血管直径<5 mm、外周动脉钙化评分系统4级、慢性完全闭塞、腘动脉段、低剂量DCB及残余狭窄。
临床怎么用
- 在股腘动脉DCB治疗中,可考虑将IVUS测得的管腔面积纳入围手术期评估,辅助风险分层、器械选择及术后监测计划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Baseline lesion characteristics have been reported to be associated with vessel patency after drug-coated balloon (DCB) treatment for femoropopliteal artery lesions. Intravascular ultrasound (IVUS) evaluation was also associated with vessel patency. The present study aimed to investigate whether the IVUS endpoints could predict the incidence of restenosis after DCB treatment, independent of classical risk factors. METHODS: We retrospectively reviewed 111 patients with 147 consecutive femoropopliteal (FP) lesions treated with IVUS-guided endovascular therapy (EVT) using DCB between 2021 and 2023. We assessed the association between 1-year restenosis and sufficient postprocedural lumen area measured by IVUS, in addition to the classical risk score, including no below-the-knee runoff, a history of EVT, distal reference vessel diameter of <5 mm, Peripheral Arterial Calcium Scoring System grade 4, chronic total occlusion (CTO), popliteal segments, low-dose DCB, and residual stenosis. The sufficient lumen area was defined as that ≥12.7 mm2. RESULTS: The chronic limb-threatening ischemia, CTO, and hemodialysis rates were 23%, 48%, and 16%, respectively. Restenosis was found in 38 lesions (26%) at 1 year. The Cox multivariate analysis showed that the classical risk score was an independent predictor of restenosis (hazard ratio [HR] = 1.45, per 1.0, P = .018), whereas sufficient lumen area was protective against restenosis (HR = 0.40, P = .015). CONCLUSION: The IVUS evaluation might be associated with restenosis onset after DCB treatment, independent of the classical risk factors.Clinical ImpactIn femoropopliteal endovascular therapy, we demonstrate that intravascular ultrasound (IVUS)-derived minimum lumen area (MLA) is an independent predictor of restenosis beyond the established predictors of patency after coated balloon angioplasty (POPCORN) risk factors. Incorporating MLA into periprocedural assessment may help with risk stratification, device selection, and planning of postprocedural surveillance.
引用
- Akai H, Horie K, Tanaka A, et al. The Utility of Intravascular Ultrasound Evaluation in Addition to the Conventional Risk Factors for Predicting Restenosis After Endovascular Therapy Using Drug-Coated Balloon in Femoropopliteal Artery Lesions. J Endovasc Ther. 2026. PMID: 42267711. doi:10.1177/15266028261453007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。